Skip Navigation LinksHome > October 2012 - Volume 20 - Issue 5 > Endolymphatic hydrops perspectives 2012
Current Opinion in Otolaryngology & Head & Neck Surgery:
doi: 10.1097/MOO.0b013e328357a6c8
HEARING SCIENCE AND VESTIBULAR MEDICINE: Edited by Rodney C. Diaz and Mohamed A. Hamid

Endolymphatic hydrops perspectives 2012

Pierce, Nathan E.; Antonelli, Patrick J.

Collapse Box


Purpose of review: Endolymphatic hydrops remains a significant cause of morbidity secondary to vertigo, hearing loss, and tinnitus. The purpose of this report is to summarize the most clinically relevant publications on endolymphatic hydrops over the past 2 years.

Recent findings: Hydrops has historically been a diagnosis of exclusion, but recent efforts has shown a role for MRI with intratympanic gadolinium. Cochrane reviews of intratympanic dexamethasone and gentamicin found inadequate level 1 evidence to support their use.

Summary: High-level evidence to guide therapy is lacking. MRI holds potential for definitive diagnosis.

© 2012 Lippincott Williams & Wilkins, Inc.


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.